Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianli Ma

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
NPJ Breast Cancer|July 12, 2023
Spatial immunophenotypes orchestrate prognosis in triple-negative breast cancer with Miller-Payne grade 4 following neoadjuvant chemotherapyJianli Ma, Yuwei Deng, Dawei Chen, et al.
Pharmaceutical Biology|May 4, 2021
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)Shuaishuai Chen, Xiaojuan Yang, Ziying Wei, et al.
British Journal of Cancer|December 9, 2025
Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancerJianli Ma, Shengnan Sun, Xiaowen Tang, et al.
Pharmacological Research|April 12, 2020
CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinomaYanan Gao, Xing Fan, Nan Li, et al.
Translational Cancer Research|December 22, 2023
Glucocorticoid receptor regulates the epithelial-mesenchymal transition process through GR/ZEB1/E-cad and is involved in breast cancer endocrine drug resistance-a bioinformatics analysisYuhan Tang, Jianli Ma, Han Zhang, et al.
Critical Reviews in Oncology/Hematology|October 28, 2023
Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theoryLei Zhang, Jianli Ma, Lei Liu, et al.
BMC Medicine|December 13, 2023
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancerZhaoyun Liu, Bo Yu, Mu Su, et al.
Journal of Nanobiotechnology|April 3, 2026
From nanotechnology to immunomodulation: emerging strategies targeting macrophages in high altitude pulmonary hypertensionYi Zhu, Xiuli Yang, Xiyu Cao, et al.
European Journal of Medicinal Chemistry|December 16, 2024
Hydroxyl-based acid-hypersensitive acetal ester bond: Design, synthesis and the application potential in nanodrugsChuanqi Wang, Hong Xu, Ying Chen, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 22, 2023
Prognostic significance of collagen signatures at breast tumor boundary obtained by combining multiphoton imaging and imaging analysisXingxin Huang, Fangmeng Fu, Wenhui Guo, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
NPJ Breast Cancer|July 12, 2023
Spatial immunophenotypes orchestrate prognosis in triple-negative breast cancer with Miller-Payne grade 4 following neoadjuvant chemotherapyJianli Ma, Yuwei Deng, Dawei Chen, et al.
Pharmaceutical Biology|May 4, 2021
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)Shuaishuai Chen, Xiaojuan Yang, Ziying Wei, et al.
British Journal of Cancer|December 9, 2025
Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancerJianli Ma, Shengnan Sun, Xiaowen Tang, et al.
Pharmacological Research|April 12, 2020
CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinomaYanan Gao, Xing Fan, Nan Li, et al.
Translational Cancer Research|December 22, 2023
Glucocorticoid receptor regulates the epithelial-mesenchymal transition process through GR/ZEB1/E-cad and is involved in breast cancer endocrine drug resistance-a bioinformatics analysisYuhan Tang, Jianli Ma, Han Zhang, et al.
Critical Reviews in Oncology/Hematology|October 28, 2023
Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theoryLei Zhang, Jianli Ma, Lei Liu, et al.
BMC Medicine|December 13, 2023
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancerZhaoyun Liu, Bo Yu, Mu Su, et al.
Journal of Nanobiotechnology|April 3, 2026
From nanotechnology to immunomodulation: emerging strategies targeting macrophages in high altitude pulmonary hypertensionYi Zhu, Xiuli Yang, Xiyu Cao, et al.
European Journal of Medicinal Chemistry|December 16, 2024
Hydroxyl-based acid-hypersensitive acetal ester bond: Design, synthesis and the application potential in nanodrugsChuanqi Wang, Hong Xu, Ying Chen, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 22, 2023
Prognostic significance of collagen signatures at breast tumor boundary obtained by combining multiphoton imaging and imaging analysisXingxin Huang, Fangmeng Fu, Wenhui Guo, et al.
Pageof 11